Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

LYSOSOMAL ENZYME RELEASE IN VIVO: AN EVALUATION OF THE MECHANISM OF COBALT POLYCYTHEMIA

Robert J. Smith, Louis J. Ignarro, Paul M. Heidger and James W. Fisher
Journal of Pharmacology and Experimental Therapeutics December 1974, 191 (3) 564-574;
Robert J. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis J. Ignarro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M. Heidger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James W. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In view of the reported findings that the lysosome-containing, light mitochondrial fraction of the kidney contains a factor which generates erythropoietin, cobalt and hypoxia, both of which are known to stimulate erythropoietin formation, were evaluated for their capacity to alter in vivo and in vitro the membrane integrity of rat kidney lysosomes. Cobalt was administered s.c. to normal rats, and other rats were rendered hypoxic by exposure to a reduced atmospheric pressure in a hypobaric chamber for various time intervals. Lysosome membrane stability in vivo was measured by assessing the effects of cobalt and hypoxia on the osmotic fragility of lysosomes. Cobalt and hypoxia provoked a labilization of lysosomal membranes in vivo as indicated by the discharge of lysosomal marker enzymes. These effects were accompanied by elevated plasma titers of acid phosphatase and β-glucuronidase activities. Cobalt failed to elicit effects in vitro on lysosome membrane integrity. Thus, the lysosome-labilizing action of cobalt can be demonstrated only in vivo, and this action may be a reflection of the capacity of cobalt to produce histotoxic hypoxia since tissue hypoxia leads to marked lysosome disruption. The in vivo data might explain, at least in part, the mechanism of action of cobalt and hypoxia in erythropoietin production.

Footnotes

    • Received February 16, 1974.
    • Accepted July 17, 1974.
  • © 1974 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 191, Issue 3
1 Dec 1974
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
LYSOSOMAL ENZYME RELEASE IN VIVO: AN EVALUATION OF THE MECHANISM OF COBALT POLYCYTHEMIA
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

LYSOSOMAL ENZYME RELEASE IN VIVO: AN EVALUATION OF THE MECHANISM OF COBALT POLYCYTHEMIA

Robert J. Smith, Louis J. Ignarro, Paul M. Heidger and James W. Fisher
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 564-574;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

LYSOSOMAL ENZYME RELEASE IN VIVO: AN EVALUATION OF THE MECHANISM OF COBALT POLYCYTHEMIA

Robert J. Smith, Louis J. Ignarro, Paul M. Heidger and James W. Fisher
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 564-574;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Response-Rate Suppression in Operant Paradigm as Predictor of Soporific Potency in Rats and Identification of Three Novel Sedative-Hypnotic Neuroactive Steroids
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics